IP Library Granted Patent US 11,237,167
Granted Patent B2
US 11,237,167 · App. 15/874,078 · Granted Feb 1, 2022

Lp-PLA2 assays and composition with detergent

Inventors: Celalettin Topbas (Wickliffe, OH); Cory Bystrom (Beachwood, OH)
Assignee: Cleveland Heartlab, Inc.
G01N33/573G01N1/28G01N2333/92G01N2800/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,237,167
App. No.
15/874,078
Granted
Feb 1, 2022
Kind
B2
Abstract

Provided herein are methods, systems, and compositions for Lp-PLA2 detection assays that employ amounts of detergent to liberate all or nearly all of the Lp-PLA2 molecules from associated lipoprotein particles. In this regard, the true Lp-PLA2 concentration can be detected in a sample, which correlates better with known Lp-PLA2 activity assays.

Claims (21)

1. A method of detecting lipoprotein-associated phospholipase A2 (Lp-PLA2) in a sample comprising:

a) contacting a sample with a first amount of a detergent mix and Lp-PLA2 binding molecules,

wherein said detergent mix comprises two or more detergents,

wherein said detergent is not CHAPS,

wherein said sample comprises Lp-PLA2 associated with lipoprotein particles,

wherein said first amount of the detergent mix is sufficient such that at least 95% of all of said Lp-PLA2 in said sample that is associated with said lipoprotein particles is liberated from said lipoprotein particles, and

wherein said Lp-PLA2 binding molecules bind to Lp-PLA2 to form complexes; and

b) detecting said complexes, thereby determining said Lp-PLA2 concentration in said sample.

2. The method of claim 1 , wherein said first amount of the detergent mix is sufficient such that at least 98% of all of said Lp-PLA2 in said sample that is associated with said lipoprotein particles is liberated from said lipoprotein particles.

3. The method of claim 1 , wherein a ratio of Lp-PLA2 concentration, in ng/ml, to Lp-PLA2 activity, in nmol/min/ml, is at least 12:1, and wherein said Lp-PLA2 activity is determined with a mass-spectrometry based activity assay.

4. The method of claim 3 , wherein said ratio is at least 13:1.

5. The method of claim 1 , wherein said sample is from a patient suspected of having, or diagnosed with, cardiovascular disease.

6. The method of claim 1 , wherein said sample is selected from the group consisting of: a serum sample, a plasma sample, and a blood sample.

7. The method of claim 1 , wherein said detergent mix comprises at least an non-ionic detergent.

8. The method of claim 1 , wherein said detergent mix comprises at least a ionic detergent.

9. The method of claim 1 , wherein said detergent mix comprises at least a zwitterionic or a chaotropic detergent.

10. The method of claim 1 , wherein said detergent mix comprises at least one detergent selected from the group consisting of: Triton X-100, Deoxycholate, sodium dodecyl sulfate, cholate, sarkosyl, n-Dodecyl β-D-maltoside (DDM), digitonin, tween 20, tween 80, and urea.

11. The method of claim 1 , wherein said Lp-PLA2 binding molecules are selected from the group of: aptamers, antibodies, and antigen-binding portions of antibodies.

12. The method of claim 1 , wherein the concentration of said first amount of the detergent mix is between 0.05% to 2%.

13. The method of claim 12 , wherein the concentration of said first amount of the detergent mix is between 0.05% to 1%.

14. The method of claim 1 , wherein said two or more detergents are selected from the group consisting of: Triton X-100, Deoxycholate, sodium dodecyl sulfate, cholate, sarkosyl, DDM, digitonin, tween 20, tween 80, and urea.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2018
From: TOPBAS, CELALETTIN; BYSTROM, CORY
To: CLEVELAND HEARTLAB, INC.
Reel/Frame 045085/0822 →
Continuity (2)
Provisional Application 62449898 · Jan 24, 2017
Related Publication 20180209977A1 · Jul 26, 2018